Clinical Trial Update: A Study to Assess the Safety and Immunogenicity of a Malaria Vaccine Candidate, R21, Administered With AS01B [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and immunogenicity of the malaria vaccine candidate R21 with AS01B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• AS01B Adjuvant System (Adjuvant system AS01B)
• R21

Snippet

Sponsor: University of Oxford | Conditions: Malaria | Phase 1 | Status: COMPLETED